Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Prostaglandin

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   43871   clinical trials with a EudraCT protocol, of which   7290   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    92 result(s) found for: Prostaglandin. Displaying page 1 of 5.
    1  2  3  4  5  Next»
    EudraCT Number: 2004-003797-28 Sponsor Protocol Number: EDMK4002 Start Date*: 2005-07-12
    Sponsor Name:Hammersmith Hospitals NHS Trust
    Full Title: A comparison of the effectiveness of prostaglandin gel and tablet preparations in induction of labour at term.
    Medical condition: Induction of Labour
    Disease:
    Population Age: Adolescents, Under 18, Adults Gender: Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2005-003211-69 Sponsor Protocol Number: LOC 06 / 2004-02 Start Date*: 2005-09-20
    Sponsor Name:Medical University of Vienna
    Full Title: Anticoagulation with Prostaglandin E1 and unfractioned Heparin versus Placebo and unfractioned Heparin during continuous venovenous hemofiltration
    Medical condition: Male and female patients with acute renal failure and treated with continuous venovenous hemofiltration therapy
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: View results
    EudraCT Number: 2017-001914-27 Sponsor Protocol Number: 13.0029 Start Date*: 2017-08-24
    Sponsor Name:St George's University Hospitals NHS Foundation Trust
    Full Title: Prostaglandin insert (Propess) versus tran-scervical balloon catheter for out-patient labour induction: A randomised controlled trial of feasibility (PROBIT-F)
    Medical condition: Induction of Labour
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2015-004012-37 Sponsor Protocol Number: HOM1-2015 Start Date*: 2015-12-18
    Sponsor Name:Ordination Dr. Hommer
    Full Title: An open, non-randomized study on the effect of changing from preserved prostaglandin formulations to preservative free tafluprost (Saflutan® Augentropfen) in patients with ocular hypertension or pr...
    Medical condition: Glaucoma / Ocular Hypertension
    Disease: Version SOC Term Classification Code Term Level
    18.1 10015919 - Eye disorders 10018307 Glaucoma and ocular hypertension HLGT
    Population Age: Adults Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: View results
    EudraCT Number: 2006-002941-35 Sponsor Protocol Number: PGMECON Start Date*: 2006-07-31
    Sponsor Name:AZIENDA OSPEDALIERA S. LUIGI GONZAGA
    Full Title: EFFECTS OF PROSTAGLANDIN COMPOUNDS ON CONJUNTIVAL MELANOGENESIS: AN IMPRESSION CITOLOGY AND TYROSINASE MARKERS STUDY
    Medical condition: EVALUATION OF CONJUNTIVAL MELANOGENESIS IN HEALTHTY VOLOUNTEERS AND GLAUCOMATOUS PATIENTS IN THERAPY WITH PROSTAGLANDIN COMOUNDS
    Disease: Version SOC Term Classification Code Term Level
    6.1 10018304 PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2006-002523-16 Sponsor Protocol Number: Ps02-S2006 Start Date*: 2006-10-13
    Sponsor Name:Synphora AB
    Full Title:
    Medical condition: Patients with mild to moderate plaque psoriasis.
    Disease: Version SOC Term Classification Code Term Level
    8.1 10050576 Psoriasis vulgaris LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: SE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2014-005468-14 Sponsor Protocol Number: OPHT-081214 Start Date*: 2015-02-24
    Sponsor Name:Medical University of Vienna, Department of Clinical Pharmacology
    Full Title: Latanoprost preserved versus unpreserved: effect on tear film thickness as measured with OCT
    Medical condition: glaucoma and ocular hypertension
    Disease: Version SOC Term Classification Code Term Level
    19.1 10015919 - Eye disorders 10018307 Glaucoma and ocular hypertension HLGT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2005-003854-80 Sponsor Protocol Number: 02B2005 Start Date*: 2006-01-31
    Sponsor Name:Department of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-University
    Full Title: Modulation of the Surgical Inflammatory Response by Etoricoxib: Peripheral versus Central
    Medical condition: Patients with osteoarthritis undergoing elective primary single hip arthroplasty
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2004-001529-88 Sponsor Protocol Number: LOC 04/2004-01 Start Date*: 2004-11-08
    Sponsor Name:Medical University of Vienna
    Full Title: Dose efficacy relation of inhalative prostaglandin I2 vs. inhalative prostaglandin E1 in patients with ARDS: comparison of efficacy with respect to paO2/FiO2 ratio, Qs/Qt and PAP.
    Medical condition: Patients suffering from ARDS who need in the moment of enrolment artificial respiration
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2008-006787-11 Sponsor Protocol Number: 0819D1522 Start Date*: 2009-01-15
    Sponsor Name:Shionogi & Co., Ltd.
    Full Title: A randomized, double blind, placebo-controlled, 2-period cross over study to evaluate effects of S-555739 on prostaglandin D2 (PGD2) induced nasal airway resistance in healthy adult volunteers
    Medical condition: Allergic rhinitis
    Disease: Version SOC Term Classification Code Term Level
    9.1 10001723 Allergic rhinitis LLT
    Population Age: Adults Gender: Male
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2021-005170-25 Sponsor Protocol Number: GNT-01-21 Start Date*: 2022-02-10
    Sponsor Name:Genetic S.p.A.
    Full Title: PHASE III MULTICENTER RANDOMIZED TRIAL OF PRESERVATIVE FREE LATANOPROST 50µG/ML VS XALATAN IN PATIENTS WITH OPEN-ANGLE GLAUCOMA OR OCULAR HYPERTENSION
    Medical condition: Patients with Open-Angle Glaucoma or ocular hypertension
    Disease: Version SOC Term Classification Code Term Level
    23.1 100000004853 10084293 Unilateral glaucoma LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2009-010101-36 Sponsor Protocol Number: Alcon SMA-08-22 Start Date*: 2009-09-21
    Sponsor Name:Alcon Laboratories, Inc.
    Full Title: The Efficacy and Safety of Adding the Brinzolamide/Timolol Maleate Fixed Combination (Azarga®) to Prostaglandin Monotherapy
    Medical condition: primary open-angle glaucoma ocular hypertension pigment dispersion glaucoma
    Disease: Version SOC Term Classification Code Term Level
    9.1 10035015 Pigmentary glaucoma LLT
    9.1 10030043 Ocular hypertension LLT
    9.1 10036719 Primary open angle glaucoma LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2004-001653-28 Sponsor Protocol Number: 03/314 Start Date*: Information not available in EudraCT
    Sponsor Name:The Leeds teaching Hospitals NHS trust
    Full Title: A comparison of the effects on prostaglandin synthesis and cytokine production of an olive-oil based lipid emulsion (Clinoloeic) with a soya based emulsion (Intralipid) in newborn infnats receiving...
    Medical condition: Prematurity Parenteral nutrition
    Disease:
    Population Age: Preterm newborn infants, Newborns, Under 18 Gender: Male, Female
    Trial protocol: GB (GB - no longer in EU/EEA)
    Trial results: (No results available)
    EudraCT Number: 2010-022433-29 Sponsor Protocol Number: LATANO-2 Start Date*: 2010-10-13
    Sponsor Name:Aarhus University Hospital, Department of Ophthalmology
    Full Title: Pharmacological intervention on diabetic retinopathy with PGF
    Medical condition: Diabetic retinopathy
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2016-001971-61 Sponsor Protocol Number: SALYCENDO Start Date*: 2016-08-29
    Sponsor Name:Radboudumc
    Full Title: The effects of acetylsalicylic acid on immunoparalysis following human endotoxemia.
    Medical condition: We will investigate the effects of acetylsalicylic acid on immunoparalysis following human endotoxemia in healthy male volunteers
    Disease:
    Population Age: Adults Gender: Male
    Trial protocol: NL (Completed)
    Trial results: View results
    EudraCT Number: 2004-000107-18 Sponsor Protocol Number: APL-202-001 Start Date*: 2006-09-29
    Sponsor Name:Alliance Pharmaceuticals
    Full Title: A RANDOMISED OPEN COMPARISON OF INTRAVAGINAL APL202 (25 or 50μg) FOLLOWED BY 25μg AFTER 4 AND 8 HOURS VERSUS 3mg OF DINOPROSTONE AS A VAGINAL TABLET FOLLOWED BY 3mg AFTER 6 HOURS IN THE INDUCTION ...
    Medical condition: Pregnancy: induction of labour
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2004-001586-18 Sponsor Protocol Number: TD-04-01 Start Date*: 2004-10-26
    Sponsor Name:Wyeth Consumer Healthcare
    Full Title: A Safety Study of TDS-943
    Medical condition: Of Product: Relieve pain and swelling in joints, muscles
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2004-000108-42 Sponsor Protocol Number: APL-202-002 Start Date*: 2004-11-04
    Sponsor Name:Alliance Pharmaceuticals
    Full Title: A RANDOMISED OPEN COMPARISON OF INTRAVAGINAL APL202 (25μg) FOLLOWED BY 25μg AFTER 4 AND 8 HOURS VERSUS 3mg of DINOPROSTONE AS A VAGINAL TABLET FOLLOWED BY 3mg AFTER 6 HOURS IN THE INDUCTION OF LAB...
    Medical condition: Pregnancy: induction of labour
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2004-002051-13 Sponsor Protocol Number: PANN3006 Start Date*: 2005-08-17
    Sponsor Name:Imperial College, London
    Full Title: A randomised double-blind placebo-controlled trial of oral misoprostol for cervical priming before outpatient hysteroscopy
    Medical condition: Abnormal uterine bleeding (hysteroscopy to investigate and treatment of abnormal uterine bleeding)
    Disease:
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: GB (GB - no longer in EU/EEA)
    Trial results: View results
    EudraCT Number: 2005-004060-24 Sponsor Protocol Number: Glaucoma Xalacam /Combigan Start Date*: 2005-11-24
    Sponsor Name:Department of Clinical Pharmacology
    Full Title: A double-masked randomized cross-over study comparing the effect of Xalacom (latanoprost/timolol) and Combigan (brimonidine/timolol) fixed combination on intraocular pressure and ocular blood flow ...
    Medical condition: Glaucoma
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  5  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sun May 05 01:54:20 CEST 2024 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA